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Background: Transcatheter aortic valve implantation (TAVI) AVI is a new percutaneous technique especially for elderly, high-risk patients with 
significant aortic valve stenosis (AS). After TAVI, the need for post-interventional PM implantation can occur. According to anecdotal experience, the 
amount and distribution of the native valve calcification seems to play an important role in predetermining the risk of pacemaker (PM) dependency 
post procedure. Aim of this study was to assess the predictability of post TAVI PM implantation probability, based on CT measured aortic annulus 
calcification and its distribution.
Methods: We prospectively analysed 81 consecutive symptomatic patients with severe AS scheduled for TAVI using the CoreValve prosthesis 
(Medtronic, Minneapolis, USA). In all patients, a native and contrast-enhanced multi-slice cardiac Computed Tomography was performed pre-
interventionally, estimating calcification load of the native valve cusps and of the adjacent outflow tract by the Agatston Score (AgS). Objective, 
computer-evaluated, pre-procedural ECG-analysis was performed with regards to pre-existing conduction abnormalities.
Results: TAVI was successful in all cases, and there were no cases of in-hospital mortality. PM implantation was deemed necessary in 32 of 
the patients. Certain pre-existing cardiac ECG abnormalities (atrial fibrillation, left hemi-block, 1st degree AV block, QRS prolongation) showed a 
significant positive correlation to post TAVI PM implantation. PM implantation correlated also to the amount of calcification of the native aortic 
valve, as assessed by the AgS and also to the localization of calcification to the non-coronary cusp.
Conclusions: PM implantation after TAVI with the Medtronic CoreValve prosthesis can be predicted with the use of a model that includes objective 
ECG data and amount and degree of native aortic valve calcification, as this is assessed by cardiac CT.
